Zyla Life Sciences Current Portion of Long-Term Debt
Zyla Life Sciences had Current Portion of Long-Term Debt of $7.80 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:LongTermDebtCurrent · last filed 2020-05-14
- 2020-03-31: Long-term Debt, Current Maturities $7.80M.
- 2019-12-31: Long-term Debt, Current Maturities $8.18M.
- 2019-09-30: Long-term Debt, Current Maturities $6.99M.
- 2019-06-30: Long-term Debt, Current Maturities $4.43M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2020-03-31 | $7.80M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $8.18M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $6.99M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.43M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.63M 10-Q · filed 2019-05-17 |